Search results
- Regulatory news (469) Apply Regulatory news filter
- Press releases (244) Apply Press releases filter
- Basic page (60) Apply Basic page filter
- Corporate presentations (29) Apply Corporate presentations filter
- Pipeline (26) Apply Pipeline filter
- Shareholder meeting (24) Apply Shareholder meeting filter
- Team member (22) Apply Team member filter
- Videos (16) Apply Videos filter
- Webcasts and audio (14) Apply Webcasts and audio filter
- Financial reports (13) Apply Financial reports filter
- Analyst (11) Apply Analyst filter
- Investor contact (5) Apply Investor contact filter
- Event (4) Apply Event filter
- Research (3) Apply Research filter
- Financial calendar (1) Apply Financial calendar filter
- Webform (1) Apply Webform filter
Notice of Interim Results
London, UK – 1 September 2021: Oxford Biomedica plc (LSE:OXB), a leading gene and cell therapy group, will be announcing its inter
Integrity and Ethics
Oxford Biomedica is committed to the highest standards of ethical conduct and integrity in its business activities in the UK and overseas.
Interim results for the six months ended 30 June 2021
Oxford Biomedica delivers record first half results